# OnCo record nct06465914 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct06465914/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct06465914", "NCT06465914" ;
  schema:name "A Phase III Study to Evaluate the Efficacy, Immunogenicity and Safety of the 9-valent HPV Vaccine in Chinese Males"@en ;
  schema:description "A phase 3 trial of HPV quadrivalent vaccine in penile cancer, run by Shanghai Bovax Biotechnology Co., Ltd., active and no longer recruiting."@en ;
  schema:url <https://onco.cc/trials/nct06465914/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT06465914> ;
  onco:status "active" ;
  onco:tag "ctgov-ingest" ;
  onco:phase "3" ;
  schema:startDate "2024-07-11" ;
  onco:cancers <https://onco.cc/cancers/penile/>, <https://onco.cc/cancers/localised-penile-cancer/> ;
  onco:technologies <https://onco.cc/technologies/hpv-vaccine/>, <https://onco.cc/technologies/interception-vaccination/> ;
  onco:drugs <https://onco.cc/drugs/hpv-quadrivalent-vaccine/> ;
  onco:companies <https://onco.cc/companies/shanghai-bovax-biotechnology/> .